Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Survival benefits of direct-acting antiviral therapy in patients with decompensated hepatitis C cirrhosis Kim, W. R., Osinusi, A., Mannalithara, A., Schall, R. A., Brainard, D. ELSEVIER SCIENCE BV. 2018: S84
View details for DOI 10.1016/S0168-8278(18)30387-8
View details for Web of Science ID 000461068600170